1.
Bioorg Med Chem Lett
; 26(17): 4216-22, 2016 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27491708
RESUMO
Design and optimization of a novel series of imidazo[1,2-b]pyridazine PDE10a inhibitors are described. Compound 31 displays excellent pharmacokinetic properties and was also evaluated as an insulin secretagogue in vitro and in vivo.